Login / Signup

CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: an international Registry.

Andrea Igoren GuaricciPier Giorgio MasciGiuseppe MuscogiuriMarco GuglielmoAndrea BaggianoLaura FusiniValentina LorenzoniChiara MartiniDaniele AndreiniAnna Giulia PavonGiovanni D AquaroAndrea BarisonGiancarlo TodiereMark G RabbatEmily TatClaudia RaineriAdele ValentiniAkos Varga-SzemesU Joseph SchoepfCarlo N De CeccoJan BogaertMonica DobrovieRolf SymonsMarta FocardiAnnalaura GismondiJordi Lozano-TorresJosè F Rodriguez-PalomaresChiara LanzilloMauro Di RomaClaudio MoroGabriella Di GiovineDavide MargonatoManuel De LazzariMartina Perazzolo MarraAlberto NeseGrazia CasavecchiaMatteo GravinaFrancesca MarzoSamuela CarigiSilvia PicaMassimo LombardiStefano CensiAngelo SqueriAlessandro PalumboNicola GaibazziGiovanni CamastraStefano SbarbatiPatrizia PedrottiAmbra MasiNazario CarrabbaSilvia PradellaMauro TimpaniGloria CicalaCristina PresicciSara PuglisiNicola SverzellatiVincenzo Ezio SantobuonoMauro PepiJuerg SchwitterGianluca Pontone
Published in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2021)
In a large multicentre, multivendor cohort registry reflecting daily clinical practice in NICM work-up, a composite clinical and CMR-based risk score provides incremental prognostic value beyond SOC evaluation, which may have impact on the indication of implantable cardioverter-defibrillator implantation.
Keyphrases
  • magnetic resonance
  • clinical practice
  • clinical trial
  • left ventricular
  • physical activity
  • cross sectional
  • heart failure
  • stem cells
  • bone marrow
  • cell therapy